Perceptive Advisors LLC Adaptive Biotechnologies Corp Transaction History

Perceptive Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $3.57 Million - $10.2 Million	-352,804 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $20.6 Million - $37.4 Million	-552,050 Reduced 61.01%	352,804 $14.2 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $3.37 Million - $4.9 Million	74,854 Added 9.02%	904,854 $53.5 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $12.5 Million - $17.1 Million	350,000 Added 72.92%	830,000 $40.4 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $374,250 - $725,700	-15,000 Reduced 3.03%	480,000 $23.2 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $3.22 Million - $6.49 Million	190,000 Added 62.3%	495,000 $13.4 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $245,600 - $328,000	10,000 Added 3.39%	305,000 $9.13 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $303,100 - $535,100	10,000 Added 3.51%	295,000 $9.12 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $11.5 Million - $13.8 Million	285,000 New	285,000 $13.8 Million

208

141M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.12B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.